Figure 2.
Comparative health care utilization in women with HHT vs VWD. (A) Rates of health care utilization to manage HHT or VWD, including hemostatic surgical procedures, ED encounters to manage BD manifestations, hospital admissions to manage BD manifestations, and outpatient encounter specialties most relevant to management of bleeding manifestations in women with HHT vs those with VWD. (B) Estimated prevalence-adjusted rates of health care utilization to manage HHT or VWD, applying adjustment to the prevalence of HHT and symptomatic VWD in the population (1 in 5000 vs 1 in 1000, so a 5× multiplier was applied to measured VWD rates).

Comparative health care utilization in women with HHT vs VWD. (A) Rates of health care utilization to manage HHT or VWD, including hemostatic surgical procedures, ED encounters to manage BD manifestations, hospital admissions to manage BD manifestations, and outpatient encounter specialties most relevant to management of bleeding manifestations in women with HHT vs those with VWD. (B) Estimated prevalence-adjusted rates of health care utilization to manage HHT or VWD, applying adjustment to the prevalence of HHT and symptomatic VWD in the population (1 in 5000 vs 1 in 1000, so a 5× multiplier was applied to measured VWD rates).

Close Modal

or Create an Account

Close Modal
Close Modal